Assessment of tumor response, AFP response, and time to progression in the phase 3 CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma (HCC) Meeting Abstract
| Authors: | Waidmann, O.; Merle, P.; Rimassa, L.; Ryoo, B. Y.; Cicin, I.; Harris, W. P.; Nemunaitis, J.; Olteanu, S.; Sarker, D.; Tan, B. R.; Van Vlierberghe, H.; Sen, S.; Love, C.; Cheng, A. L.; El-Khoueiry, A. B.; Meyer, T.; Kelley, R. K.; Abou-Alfa, G. K. |
| Abstract Title: | Assessment of tumor response, AFP response, and time to progression in the phase 3 CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma (HCC) |
| Meeting Title: | Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 41 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2018 Sep 28-Oct 2 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2018-09-01 |
| Start Page: | 283 |
| End Page: | 284 |
| Language: | English |
| ACCESSION: | WOS:000446816500689 |
| PROVIDER: | wos |
| PUBMED: | 30261496 |
| DOI: | 10.1159/000492737 |
| Notes: | Meeting Abstract: P880 -- Source: Wos |
